In 1983, the heartburn drug, Zantac was approved as a prescription drug in the U.S. It went from one of the world’s best-selling drugs to being pulled from store shelves.
Nearly four decades later, the FDA ordered Zantac and its generics be removed from the market, saying they have been exposing consumers to the risk of cancer.
Exposure to high amounts of NDMA, (Nitrosodimethylamine), is thought to cause gastric or colorectal cancer, according to the World Health Organization. It’s extremely toxic to the liver. Even small amounts may be linked to liver damage.
Both Zantac and ranitidine contain high levels of NDMA, and research indicates that the NDMA forms when the active ingredient, ranitidine is exposed to heat and humidity.
Evidence suggests that the manufacturers of Zantac knew of ranitidine’s ability to break down into NDMA since before the drug was put on the market.
However, despite this knowledge, they never issued any warning, or added any information to the label to warn customers of this danger.
Willie “Marcus” Fields, Levin Papantonio Rafferty’s client, used Zantac from 1995 until 2010 and as a result he developed Bladder, Stomach, Prostate, and Liver cancer.
IN THIS INSIDER EXCLUSIVE NETWORK TV SPECIAL, Justice in America – Zantac Lawsuit Update– What You Need to Know – Willie ‘Marcus’ Fields’s Story” our News team is on location in Pensacola, Florida to meet with Madeline Pendley, trial lawyer at Levin Papantonio Rafferty.
In this Network TV Special, Madelyn will explain some of the very important issues you should know, such as:
The Deadly Dangers of Zantac, their high levels of the carcinogen, NDMA and how it affects human beings?
When Did Consumers Become Aware That Zantac Was Dangerous?
How the manufacturers of Zantac knew of ranitidine’s ability to break down into NDMA since before the drug was put on the market. These companies knew that ranitidine breaks down when exposed to heat and humidity since it was first invented. And they quickly learned that it was breaking down into NDMA.
And despite this knowledge, they never issued any warning, or added any information to the label to warn customers of this danger.
She will explain the legal Strategies to successfully prosecute this case on behalf of a multitude of potential victims, and the status of this Multi District Litigation (MDL) currently.
She will also explain the tremendous amount of research their experts they already done, ultimately landed on 5 cancers that are uniformly supported across the literature. These are the cancers that are moving forward in the MDL litigation right now. Those 5 cancers are: Liver cancer; Bladder cancer; Gastric cancer; Esophageal cancer and Pancreatic cancer.
Please contact Levin Papantonio Rafferty, Mike Papantonio and Wes Bowden @ https://www.levinlaw.com/ 800 277 1193